FILE:CAH/CAH-8K-20050309080431.txt.gz
EVENTS:	Regulation FD Disclosure	Financial Statements and Exhibits
TEXT:
ITEM: Regulation FD Disclosure
ITEM: Financial Statements and Exhibits
 
 
 
      Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (General Instruction A.2. below):
see
       Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
       Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
       Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
 
 
 
Item 7.01 Regulation FD Disclosure
      As previously announced, Jim Hinrichs, Vice President of Investor Relations of Cardinal Health, Inc. (the "Company"), is scheduled to address investors at the Raymond James 26th Annual Institutional Investors Conference Wednesday, March 9 at 8:40 a.m. eastern standard time. Mr. Hinrichs will discuss the Company's diverse products and services, its performance, including fiscal 2005 financial performance, and its strategies for continued growth. Mr. Hinrichs' remarks and slide presentation will be webcast live at www.wsw.com/webcast/rjii05/cah/. An archive of the webcast will be available through the same link for 90 days. The Company is furnishing Mr. Hinrichs' slide presentation for the conference as an exhibit to this Form 8-K.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
      Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

 
Exhibit 99.01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


